# Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer

> **NCT00219297** · PHASE2 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 50 (actual)

## Conditions studied

- Brain Metastasis
- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Patupilone

## Key facts

- **NCT ID:** NCT00219297
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11-16
- **Primary completion:** 2010-06-24
- **Final completion:** 2010-06-24
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2021-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00219297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00219297, "Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00219297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*